GSK
GSK
GSK
1,025 hedge funds and large institutions have $20.7B invested in GSK in 2026 Q1 according to their latest regulatory filings, with 140 funds opening new positions, 313 increasing their positions, 379 reducing their positions, and 82 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
3% more funds holding
Funds holding: 992 → 1,025 (+33)
1.11% less ownership
Funds ownership: 19.53% → 18.42% (-1.1%)
17% less repeat investments, than reductions
Existing positions increased: 313 | Existing positions reduced: 379
Holders
1,025
Holding in Top 10
15
Calls
$222M
Puts
$137M
Top Buyers
| 1 | +$282M | |
| 2 | +$154M | |
| 3 | +$127M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$111M |
| 5 |
BlackRock
New York
|
+$94.1M |
Top Sellers
| 1 | -$534M | |
| 2 | -$292M | |
| 3 | -$227M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$145M |
| 5 |
Holocene Advisors
New York
|
-$141M |
